Skip to main content
Premium Trial:

Request an Annual Quote

Invitae, OptraHealth Resolve Chatbot Patent Dispute

NEW YORK – OptraHealth and Invitae forged an agreement to resolve a patent dispute related to a chatbot technology that automates the return of genetic test results to patients.

OptraHealth had previously sued Invitae for patent infringement, three months after Invitae sued OptraHealth for the same.

As part of the agreement, OptraHealth will license its patent to Invitae and Invitae's customers while both companies continue to offer their own respective products and services.

While the agreement fully resolves the litigation between the two companies, other details of the agreement were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.